Development and Validation of the Visual Medical Scale to Evaluate Nail Psoriasis Severity (ViSENPsO®) - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Creation and Assessment of the Visual Medical Scale for Measuring Nail Psoriasis Severity (ViSENPsO®)

  • By

  • Adilson DaCosta

  • Cláudio de Lélis Filgueiras de Souza

  • Renan Minotto

  • Selam Shah

  • Olga Moshkovich

  • James P. Stansbury

  • Siu-Long Yao

  • April 30, 2026

Share

Objective:

To develop a standardized, validated tool for evaluating fingernail psoriasis severity that addresses limitations of existing assessment tools.

Approach:
    Key Findings:
    • ViSENPsO provides a user-friendly alternative to existing tools, improving consistency and reliability in nail psoriasis assessment.
    • The scale was developed through rigorous qualitative and quantitative methodologies involving both clinicians and patients.
    • Further psychometric validation is needed in larger, diverse populations to confirm its applicability.
    Interpretation:

    The ViSENPsO scale addresses the shortcomings of the Nail Psoriasis Severity Index by offering a more precise and reliable method for assessing nail psoriasis severity.

    Limitations:
    • Further validation in larger and more diverse populations is required.
    • The study primarily involved dermatologists and patients from specific regions, which may limit generalizability.
    Conclusion:

    The ViSENPsO scale represents a significant advancement in the assessment of nail psoriasis severity, with potential for improved outcomes in clinical trials.

Original Source(s)

Related Content